F.D.A. Panel Approves Use of Antidepressant for Pain
Thursday, August 19, 2010 - 15:28
in Mathematics & Economics
An advisory committee votes to allow Eli Lilly to market Cymbalta for chronic pain, especially back ailments.
An advisory committee votes to allow Eli Lilly to market Cymbalta for chronic pain, especially back ailments.